Tag Archives: Alzheimer’s Disease

Georgia House Approves Medical Marijuana Expansion Bill

Georgia House Approves Medical Marijuana Expansion Bill

Georgia House Approves Medical Marijuana Expansion Bill

On March 1, 2017, the Georgia House of Representatives voted to approve House Bill 65, which would expand the number of qualifying conditions covered by the state’s limited medical marijuana program.

SeeThruEquity RSHO Raúl Elizalde

Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™

SAN DIEGO, Calif., Feb., 7, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country suffering from Alzheimer’s disease.

Grow Blox

Growblox Sciences Announces Patent Application for Treatments of Parkinson’s Disease, Alzheimer’s Disease, Huntington’s Disease and Dementia

LAS VEGAS, Oct. 12, 2016 /Weed Wire/ — Growblox Sciences, Inc. (OTCQB: GBLX) is pleased to announce the filing of the first of several patent applications for life science inventions by its wholly-owned subsidiary, Growblox Life Sciences, LLC.

medical marijuana

Ohio’s New Medical Marijuana Law Surrounded by Uncertainties

As Ohio’s new medical marijuana law goes into effect, stakeholders have more questions than answers, according to a Sept. 8, 2016, article by the Associated Press. The new law went into effect on Sept. 8, 2016, making Ohio the 25th state to have legalized medical marijuana, but Ohio does not have dispensaries at which qualified patients can buy it.